Jacob Stein, MD, MPH, discusses how nab-sirolimus improves outcomes for patients with advanced perivascular epithelioid cell tumors compared with other treatments or no treatment options.
Jacob Stein, MD, MPH
Jacob Stein, MD, MPH, is a medical oncologist with a clinical focus on caring for patients with sarcomas at UNC School of Medicine.
Articles by Jacob Stein, MD, MPH
Latest Updated Articles
Nab-Sirolimus and Its Role in PEComa TreatmentPublished: October 25th 2024 | Updated: